Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on May 12, 2025
New Wave Announces Shares for Debt Settlements
GlobeNewswire
·
May 12, 2025
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (the “Company” or “New Wave”) (CSE: NWAI, FWB: 0XM0, OTCPK: TRMNF) announces the Company has entered into debt settlement agreements for an aggregate of $348,640 in debt …
BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Enrollment complete in SERENITY At-Home pivotal Phase 3 safety trial for acute treatment of agitation associated with bipolar disorders or schizophrenia Topline data expected in second half of 2025 intended to support potential sNDA submission for label …
AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting
GlobeNewswire
·
May 12, 2025
MILAN, May 12, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announces the presentation of two …
Tiziana Life Sciences Announces Purchase of Shares by Chairman
GlobeNewswire
·
May 12, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully …
Kaspi.kz 1Q 2025 Financial Results
GlobeNewswire
·
May 12, 2025
ALMATY, Kazakhstan, May 12, 2025 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”) (Nasdaq:KSPI) which operates the Kaspi.kz and Kaspi Pay Super Apps in Kazakhstan and owns 65.41% of Hepsiburada in Türkiye, today published its unaudited …
CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
GlobeNewswire
·
May 12, 2025
SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced the pricing of an underwritten offering of 76,923,076 …
Pharvaris to Host a Virtual R&D Call “Deucrictibant: Beyond HAE Type 1/2” on June 4
GlobeNewswire
·
May 12, 2025
ZUG, Switzerland, May 12, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such …
Fortrea Reports First Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
For the three months ended March 31, 2025, from continuing operations: Revenues of $651.3 million GAAP net loss of $(562.9) million, inclusive of a non-cash goodwill impairment charge Adjusted EBITDA of $30.3 million GAAP and adjusted net (loss) income per …
Fortrea Announces CEO Stepping Down
GlobeNewswire
·
May 12, 2025
DURHAM, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that Thomas Pike is stepping down from his role as Fortrea’s Chief Executive Officer and as …
CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)
GlobeNewswire
·
May 12, 2025
- 28% confirmed response rate (5/18) per RECIST v1.1 in unselected patients across doses prioritized for expansion (7.2, 8.6 and 10 mg/kg Q3W) - - 3 of 7 evaluable patients (43%) with confirmed responses at upper expansion dose (10 mg/kg Q3W) - - Median …
CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
- Announced Positive Interim Data From Ongoing Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) in Patients with Advanced Colorectal Cancer (CRC) - - Initiated CX-2051 Phase 1 dose expansions at 7.2 mg/kg, 8.6 mg/kg, and 10 mg/kg …
Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling First patient dosed in Phase 1b trial of APG777 in mild-to-moderate asthma with readout expected in 1H 2026 …
KANZHUN LIMITED to Report First Quarter 2025 Results on May 22, 2025
GlobeNewswire
·
May 12, 2025
BEIJING, May 12, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it will report its unaudited consolidated results for the first …
Apogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate Asthma
GlobeNewswire
·
May 12, 2025
Multiple doses of APG808 resulted in rapid suppression of FeNO, a biomarker of Type 2 inflammation associated with exacerbations in asthma, with a robust maximal FeNO decrease from baseline of 53% APG808 demonstrated the potential for durable disease …
Cybersecurity Veteran Kevin Mandia joins DTEX’s Advisory Board
GlobeNewswire
·
May 12, 2025
Founder of Mandiant and advisor to global governments and Boards will support the company’s insider-risk mission SAN JOSE, Calif. , May 12, 2025 (GLOBE NEWSWIRE) -- DTEX Systems, the trusted leader of insider risk management, today announced the …
Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
GlobeNewswire
·
May 12, 2025
New litigation filed against Liquidia in U.S. District Court for the Middle District of North Carolina alleges infringement of UTHR’s ‘782 patent and seeks to enjoin Liquidia from commercializing YUTREPIA ‘782 patent claims same general subject matter as …
Aerospike Automates Database 8 Deployment on Amazon EKS
GlobeNewswire
·
May 12, 2025
MOUNTAIN VIEW, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Aerospike, Inc. today delivered a new Terraform blueprint that quickly deploys Database 8 on Amazon EKS in under 30 minutes. The Aerospike Kubernetes Operator (AKO) automates the deployment and …
النسخة المعدلة من البيان الصحفي – مع تعديلات مميزة
GlobeNewswire
·
May 12, 2025
دولة الإمارات العربية المتحدة تستضيف قمة تاريخية لتحديد ملامح عصر جديد في حوكمة التكنولوجيا الناشئة أكثر من 2,000 مشترك من أكثر من عشرون دولة يشاركون في جلسات حوارية هامة أُقيمت على مدار يومين في أبوظبي أبوظبي، دولة الإمارات العربية المتحدة , May 12, 2025 …
UAE Hosts Landmark Summit to Chart a New Era in Emerging Tech Governance
GlobeNewswire
·
May 12, 2025
More than 2,000 participants from over 20 countries gathered in Abu Dhabi for two days of high-level discussions ABU DHABI, United Arab Emirates, May 12, 2025 (GLOBE NEWSWIRE) -- The Governance of Emerging Technologies Summit (GETS 2025) concluded this …
Les Émirats Arabes Unis organisent un sommet marquant, augurant une nouvelle ère en matière de gouvernance pour les technologies émergentes
GlobeNewswire
·
May 12, 2025
Plus de 2000 participants issus de 20 pays se sont réunis à Abou Dhabi pour 2 jours remplis de discussions de haut niveau ABOU DHABI, Émirats Arabes Unis, 12 mai 2025 (GLOBE NEWSWIRE) -- Le Sommet sur la Gouvernance des Technologies Émergentes (GETS 2025) …